Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does POLATUZUMAB VEDOTIN Cause Anaemia? 344 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 344 reports of Anaemia have been filed in association with POLATUZUMAB VEDOTIN (POLIVY). This represents 7.3% of all adverse event reports for POLATUZUMAB VEDOTIN.

344
Reports of Anaemia with POLATUZUMAB VEDOTIN
7.3%
of all POLATUZUMAB VEDOTIN reports
48
Deaths
127
Hospitalizations

How Dangerous Is Anaemia From POLATUZUMAB VEDOTIN?

Of the 344 reports, 48 (14.0%) resulted in death, 127 (36.9%) required hospitalization, and 25 (7.3%) were considered life-threatening.

Is Anaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for POLATUZUMAB VEDOTIN. However, 344 reports have been filed with the FAERS database.

What Other Side Effects Does POLATUZUMAB VEDOTIN Cause?

Disease progression (1,131) Off label use (692) Blood lactate dehydrogenase increased (307) Drug ineffective (305) Neutropenia (303) Death (295) Covid-19 (286) Febrile neutropenia (286) Pyrexia (285) Thrombocytopenia (265)

What Other Drugs Cause Anaemia?

LENALIDOMIDE (5,322) CARBOPLATIN (5,312) RIBAVIRIN (5,130) ASPIRIN (4,568) CYCLOPHOSPHAMIDE (4,486) RITUXIMAB (4,399) DEXAMETHASONE (4,352) ADALIMUMAB (3,994) PACLITAXEL (3,949) METHOTREXATE (3,913)

Which POLATUZUMAB VEDOTIN Alternatives Have Lower Anaemia Risk?

POLATUZUMAB VEDOTIN vs POLATUZUMAB VEDOTIN-PIIQ POLATUZUMAB VEDOTIN vs POLIDOCANOL POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350 POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM

Related Pages

POLATUZUMAB VEDOTIN Full Profile All Anaemia Reports All Drugs Causing Anaemia POLATUZUMAB VEDOTIN Demographics